STAGE IV PROSTATE CANCER AJCC V7
Clinical trials for STAGE IV PROSTATE CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo targets Cancer's Self-Eating process
Disease control OngoingThis early-phase trial tests the safety and best dose of combining two drugs—MK-2206 and hydroxychloroquine—in people with advanced solid tumors, melanoma, or prostate or kidney cancer. The goal is to see if blocking a process called autophagy can help kill more cancer cells. Abo…
Matched conditions: STAGE IV PROSTATE CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New drug cocktail shows promise for Hard-to-Treat prostate cancer
Disease control OngoingThis study tests a combination of two drugs—cabazitaxel (a chemotherapy) and enzalutamide (a hormone blocker)—in men with prostate cancer that has spread and stopped responding to standard hormone therapy. The goal is to find the safest dose and see if the combo can lower PSA lev…
Matched conditions: STAGE IV PROSTATE CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:32 UTC